Genpact Deferred Long Term Liab from 2010 to 2024

G Stock  USD 46.19  0.37  0.81%   
Genpact's Deferred Long Term Liabilities is increasing over the last several years with slightly volatile swings. Deferred Long Term Liabilities is estimated to finish at about 269.8 M this year. Deferred Long Term Liabilities is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. View All Fundamentals
 
Deferred Long Term Liabilities  
First Reported
2010-06-30
Previous Quarter
3.8 M
Current Value
210.9 M
Quarterly Volatility
65.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Genpact financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genpact's main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.3 M or Interest Expense of 29.9 M, as well as many indicators such as Price To Sales Ratio of 2.31 or Dividend Yield of 0.0242. Genpact financial statements analysis is a perfect complement when working with Genpact Valuation or Volatility modules.
  
Check out the analysis of Genpact Correlation against competitors.

Latest Genpact's Deferred Long Term Liab Growth Pattern

Below is the plot of the Deferred Long Term Liab of Genpact Limited over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Genpact's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genpact's overall financial position and show how it may be relating to other accounts over time.
Deferred Long Term Liab10 Years Trend
Slightly volatile
   Deferred Long Term Liab   
       Timeline  

Genpact Deferred Long Term Liab Regression Statistics

Arithmetic Mean69,051,662
Geometric Mean11,301,222
Coefficient Of Variation161.65
Mean Deviation95,022,171
Median6,068,000
Standard Deviation111,623,899
Sample Variance12459.9T
Range268.2M
R-Value0.77
Mean Square Error5360.7T
R-Squared0.60
Significance0.0007
Slope19,341,796
Total Sum of Squares174438.5T

Genpact Deferred Long Term Liab History

2024269.8 M
2023256.9 M
2022223.4 M
2021238.8 M
20201.5 M
2019M
20188.1 M

About Genpact Financial Statements

Genpact stakeholders use historical fundamental indicators, such as Genpact's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Genpact investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genpact's assets and liabilities are reflected in the revenues and expenses on Genpact's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genpact Limited. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Deferred Long Term Liabilities256.9 M269.8 M

Currently Active Assets on Macroaxis

Check out the analysis of Genpact Correlation against competitors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.156
Dividend Share
0.595
Earnings Share
3.64
Revenue Per Share
25.964
Quarterly Revenue Growth
0.066
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.